AKYNZEO® recommended by NCCN and ASCO

Guideline Recommendations
AKYNZEO is a recommended option in the NCCN antiemesis guidelines and the ASCO antiemesis guidelines1,2
  • NCCN recommends that patients receiving highly emetogenic chemotherapy (including anthracycline plus cyclophosphamide) and moderately emetogenic chemotherapy receive AKYNZEO in combination with dexamethasone1
  • ASCO recommends that all patients who receive highly emetogenic chemotherapy regimens should be offered the oral combination of netupitant and palonosetron plus dexamethasone as an additional treatment option2
NCCN=National Comprehensive Cancer Network.
ASCO=American Society of Clinical Oncology.